Review Articles Concerning Pulmonary Vascular Disease

Atrial Septal Defects: From Embryology to Pediatric Pulmonary Hypertension

Elzbieta Bartoszewska, Anna Chrapkowska, Oliwia Zielinska, Maria Mordalska, Julia Lizon, Zuzanna Zalewska, Marek WasicionekWroclaw Medical University. Poland Journal of Clinical MedicineJ Clin Med 2025; 14: DOI: 10.3390/jcm14217698 AbstractAtrial septal defect (ASD) is characterized by an abnormal opening between the left (LA) and right atria (RA). Even though it’s one of the most prevalent congenital heart defects, […]

Atrial Septal Defects: From Embryology to Pediatric Pulmonary Hypertension Read More »

Pulmonary vascular complications in children who survive long-term after Kasai portoenterostomy for biliary atresia: a narrative review

Jie Zhang, Gong ChenChildren’s Hospital of Fudan University.China World Journal of Pediatric SurgeryWorld J Pediatr Surg 2025; 8: DOI: 10.1136/wjps-2025-001067 AbstractFollowing Kasai portoenterostomy for biliary atresia (BA), long-term survival in children is associated with chronic liver cirrhosis leading to hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PoPH). This further causes a diverse array of respiratory and circulatory

Pulmonary vascular complications in children who survive long-term after Kasai portoenterostomy for biliary atresia: a narrative review Read More »

Kidney and vascular involvement in Alagille syndrome

Bruno Ranchin, Marie‑Noelle Meaux, Malo Freppel, Mathias Ruiz, Aurelie De MulHôpital Femme Mère Enfant, Hospices Civils de Lyon and Université de Lyon.France Pediatric NephrologyRediatr Nephrol 2025; 40: 891-899DOI: 10.1007/s00467-024-06562-8 AbstractAlagille syndrome (ALGS) is an autosomal dominant, multisystemic disease with a high interindividual variability. The two causative genes JAG1 and NOTCH2 are expressed during kidney development, can

Kidney and vascular involvement in Alagille syndrome Read More »

Treatment options for children with pulmonary arterial hypertension associated with congenital heart disease

Julie Wacker, Raphael Joye, Maurice BeghettiGeneva University Hospitals.Switzerland Expert Review of Respiratory MedicineExpert Rev Respir Med 2025; DOI: 10.1080/17476348.2025.2581340 AbstractIntroduction: Pulmonary hypertension associated with congenital heart disease (PAH-CHD) represents one of the leading causes of pediatric pulmonary hypertension. Within this entity, patients can be classified into distinct subgroups, each characterized by specific clinical features, pathophysiological mechanisms, and

Treatment options for children with pulmonary arterial hypertension associated with congenital heart disease Read More »

Persistent Pulmonary Hypertension of the Newborn: A Pragmatic Review of Pathophysiology, Diagnosis, and Advances in Management

Karolina Chojnacka, Yogen Singh, Sheen Gahlaut, Witold Blaz, Agata Jerzak, Tomasz SzczapaPoznan University of Medical Sciences. University of California and UC Davis Children’s Hospital. Oxford University. Saint Jadwiga the Queen Clinical Provincial Hospital and University of Rzeszow.Poland, United States and United Kingdom BiomedicinesBiomedicines 2025; 13: DOI: 10.3390/biomedicines13102332 AbstractPersistent pulmonary hypertension of the newborn (PPHN) results from

Persistent Pulmonary Hypertension of the Newborn: A Pragmatic Review of Pathophysiology, Diagnosis, and Advances in Management Read More »

Vascular and Non-Vascular Intervention in the Pediatric Chest: An Update

Sunit Davda, Ajit Yadav, Manish Patel, Matt HawkinsGreat Ormond Street Hospital. Sir Ganga Ram Hospital. Cincinnati Children’s Hospital Medical Center. Emory University School of Medicine and Children’s Healthcare of Atlanta.United Kingdom, India and United States CardioVascular and Interventional RadiologyCardiovasc Interv Radiol 2025; DOI: 10.1007/s00270-025-04226-0 AbstractIn pediatric patients, thoracic intervention can involve aerodigestive tract, pleura, pulmonary parenchymal,

Vascular and Non-Vascular Intervention in the Pediatric Chest: An Update Read More »

Role of lipid droplets in pulmonary arterial hypertension: focusing on pulmonary artery smooth muscle cell proliferation

Baishi Huang, Yu Hao, Zhe Wen, Jie Dong, Shengwei Jin, Hui LiSecond Affiliated Hospital, Yuying Children’s Hospital and Wenzhou Medical University. China Lipids in Health and DiseaseLipids Health Dis 2025; 24:DOI: 10.1186/s12944-025-02746-9 AbstractPulmonary arterial hypertension (PAH) is a devastating disease complicated by pathological features such as proliferation of pulmonary artery smooth muscle cells (PASMCs), vasoconstriction, increased

Role of lipid droplets in pulmonary arterial hypertension: focusing on pulmonary artery smooth muscle cell proliferation Read More »

“Gentle” cardio-respiratory management in congenital diaphragmatic hernia: Time for a precision-medicine approach?

Anna Foth, David Tingay, Florian KipfmuellerUniversity Medical Center Mannheim and Heidelberg University. Murdoch Children’s Research Institute and University of Melbourne. Germany and Australia Seminars in Fetal and Neonatal MedicineSemin Fetal Neonatal Med 2025; DOI: 10.1016/j.siny.2025.101660 AbstractCongenital diaphragmatic hernia (CDH) remains one of the most challenging conditions to manage in neonatal intensive care, with outcomes determined by

“Gentle” cardio-respiratory management in congenital diaphragmatic hernia: Time for a precision-medicine approach? Read More »

Chronic Lung Disease-Related Pulmonary Hypertension in Children

Jason E. Lang, Kevin D. HillDuke Clinical Research Institute and Duke University School of Medicine. United States Acta PaediatricaActa Paediatr 2025; DOI: 10.1111/apa.70320 AbstractAim: Pulmonary hypertension (PH) is characterised by elevated pressures in the pulmonary arterial system. Despite its high mortality, paediatric PH has few approved treatments. Our aim was to review the latest diagnostic and treatment

Chronic Lung Disease-Related Pulmonary Hypertension in Children Read More »

Pharmacology in Congenital Diaphragmatic Hernia: A Focus on Cardiovascular Management

Anie Lapointe, Florian Kipfmueller, Neil Patel, Gabriel AltitCHU Sainte-Justine. University Medical Center Mannheim and University of Heidelberg. Royal Hospital for Children. Montreal Children’s Hospital and McGill University Health Centre Research Institute.Canada, Germany and United Kingdom NeoreviewsNeoreviews 2025; 26: e660-e678DOI: 10.1542/neo.26-10-060 AbstractCongenital diaphragmatic hernia (CDH) presents a complex challenge in neonatal care, requiring tailored pharmacological strategies to

Pharmacology in Congenital Diaphragmatic Hernia: A Focus on Cardiovascular Management Read More »

Scroll to Top